US HB5381 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on December 10 2019 - 25% progression, died in committee
Action: 2019-12-11 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on December 10 2019 - 25% progression, died in committee
Action: 2019-12-11 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug to list the country of origin of each of the drug's active ingredients.
Title
International Pharmaceutical Transparency Act of 2019
Sponsors
Rep. Scott DesJarlais [R-TN] |
History
Date | Chamber | Action |
---|---|---|
2019-12-11 | House | Referred to the Subcommittee on Health. |
2019-12-10 | House | Referred to the House Committee on Energy and Commerce. |
2019-12-10 | House | Introduced in House |
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/5381/all-info |
Text | https://www.congress.gov/116/bills/hr5381/BILLS-116hr5381ih.pdf |